F.D.A. Faces Upset Over Denials of New Drugsnews2026-03-05T19:26:40+00:00March 5th, 2026|The New York Times|
F.D.A. Turmoil Keeps Spotlight on Its Commissionernews2025-12-19T16:11:23+00:00December 19th, 2025|The New York Times|
New Gene-Editing Strategy Could Help Development of Treatments for Rare Diseasesnews2025-11-20T00:06:22+00:00November 20th, 2025|The New York Times|
These Patients Got the Cure. Then It Went Away.news2025-09-22T22:35:25+00:00September 22nd, 2025|The New York Times|
Top F.D.A. Official Resigns Under Pressurenews2025-07-30T02:59:00+00:00July 30th, 2025|The New York Times|
Drugmakers Notch a $5 Billion Win in Republicans’ Policy Billnews2025-07-03T19:02:53+00:00July 3rd, 2025|The New York Times|
Los médicos le dijeron que iba a morir, pero la IA le salvó la vidanews2025-03-23T07:00:32+00:00March 23rd, 2025|The New York Times|
Drugs Have Uses We Can’t Imagine. He’s Using A.I. to Find Them.news2025-03-20T15:00:12+00:00March 20th, 2025|The New York Times|
Can Marty Makary Handle the F.D.A’.s Central Dilemma?news2025-03-06T10:00:26+00:00March 6th, 2025|The New York Times|
Gene Therapies Could Transform Rare Diseases. Are We Holding Them Back?news2024-02-19T22:47:36+00:00February 19th, 2024|The New York Times|
